Furthermore, γ-H2AX has been reported as a prognostic factor in several other types of cancers, including breast cancer [30], hepatocellular carcinoma [29], lung cancer [31], and colorectal cancer [32], in which γ-H2AX overexpression has been associated with poor patient survival. Here, H2AX is linked to breast cancer.